0001420108-26-000006.txt : 20261007 0001420108-26-000006.hdr.sgml : 20261007 20261007172713 ACCESSION NUMBER: 0001420108-26-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261007 DATE AS OF CHANGE: 20261007 EFFECTIVENESS DATE: 20261007 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Glucose Health, Inc. CENTRAL INDEX KEY: 0001420108 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 901117742 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-600381 FILM NUMBER: 261447753 BUSINESS ADDRESS: STREET 1: 609 SW 8TH STREET, SUITE 600 CITY: BENTONVILLE STATE: AR ZIP: 72712 BUSINESS PHONE: 479-802-3827 MAIL ADDRESS: STREET 1: 609 SW 8TH STREET, SUITE 600 CITY: BENTONVILLE STATE: AR ZIP: 72712 FORMER COMPANY: FORMER CONFORMED NAME: Bio-Solutions Corp. DATE OF NAME CHANGE: 20071203 D 1 primary_doc.xml X0708 D LIVE 0001420108 Glucose Health, Inc. 609 SW 8TH STREET, SUITE 600 BENTONVILLE AR ARKANSAS 72712 479-802-3827 DELAWARE Bio-Solutions Corp. Corporation true John Duffy 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Executive Officer Director Mark Schaftlein 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director Edmund Burke 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director Christopher Jemapete 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director Marc Hatch 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Executive Officer Other Health Care $1 - $1,000,000 06b false 2026-09-22 false true false 0 172500 172500 0 Amount represents value of additional restricted shares issued to recipient for services rendered to the Issuer. false 1 0 0 0 true false Glucose Health, Inc. /s/ John Duffy John Duffy CEO 2026-10-07